30
Walvax Biotech
300142.SZ·SZSEKunming CNFounded 20015,000 employees
Mid CapbiotechPublicInfectious Disease
Platform: mRNA Vaccine
Market Cap
$3B
All Drugs
3
Clinical Trials
4
Failed / Terminated
0
FDA Approved
0
Stock Price & Catalysts (300142.SZ)
Loading 300142.SZ stock data...
Drug Pipeline (3 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| Tiratuximab | 300-6443 | Phase 2 | 2 | HER2 | Heart Failure | ||
| Lisoderotide | 300-2191 | Phase 1/2 | 1 | FcRn | CLLMG | ||
| 300-6800 | 300-6800 | Phase 1/2 | 1 | EGFR | IPF |
SEC Filings & Financial Documents
SEC filings are not available for SZSE-listed companies.
Walvax Biotech trades on SZSE (CN). SEC EDGAR only covers US-listed issuers.
Insider Trading Activity
Insider trading data is not available for non-US exchanges.
Catalyst Events (3)